О. В. Аверков

3.4k total citations
48 papers, 181 citations indexed

About

О. В. Аверков is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Infectious Diseases. According to data from OpenAlex, О. В. Аверков has authored 48 papers receiving a total of 181 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Cardiology and Cardiovascular Medicine, 13 papers in Surgery and 7 papers in Infectious Diseases. Recurrent topics in О. В. Аверков's work include Acute Myocardial Infarction Research (12 papers), Antiplatelet Therapy and Cardiovascular Diseases (11 papers) and COVID-19 Clinical Research Studies (7 papers). О. В. Аверков is often cited by papers focused on Acute Myocardial Infarction Research (12 papers), Antiplatelet Therapy and Cardiovascular Diseases (11 papers) and COVID-19 Clinical Research Studies (7 papers). О. В. Аверков collaborates with scholars based in Russia, Canada and United States. О. В. Аверков's co-authors include Е.П. Павликова, Yu. V. Kotovskaya, Diego Albrecht, Surya Ayalasomayajula, Margaret F. Prescott, Thomas Langenickel, Pierre J. Jordaan, Priya Chandra, Iris Rajman and Parasar Pal and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and American Heart Journal.

In The Last Decade

О. В. Аверков

30 papers receiving 176 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
О. В. Аверков Russia 6 134 28 25 22 16 48 181
Hitomi Yuzawa Japan 8 191 1.4× 24 0.9× 18 0.7× 21 1.0× 30 1.9× 45 234
Shunsuke Kiuchi Japan 10 149 1.1× 47 1.7× 32 1.3× 35 1.6× 19 1.2× 35 204
Sergio Agosti Italy 8 77 0.6× 15 0.5× 13 0.5× 12 0.5× 11 0.7× 19 153
Bernard Kadosh United States 5 77 0.6× 34 1.2× 26 1.0× 25 1.1× 18 1.1× 26 161
Khalid S Ibrahim Jordan 8 108 0.8× 65 2.3× 12 0.5× 27 1.2× 14 0.9× 31 190
Michael Ke Wang Canada 8 93 0.7× 29 1.0× 31 1.2× 17 0.8× 7 0.4× 26 160
Harilaos Bogossian Germany 12 346 2.6× 37 1.3× 15 0.6× 54 2.5× 43 2.7× 79 406
V. A. Sulimov Russia 8 216 1.6× 31 1.1× 11 0.4× 25 1.1× 6 0.4× 40 238
Margaret Infeld United States 10 355 2.6× 33 1.2× 34 1.4× 23 1.0× 7 0.4× 32 401
Andrzej Skrobowski Poland 9 166 1.2× 53 1.9× 41 1.6× 13 0.6× 13 0.8× 36 228

Countries citing papers authored by О. В. Аверков

Since Specialization
Citations

This map shows the geographic impact of О. В. Аверков's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by О. В. Аверков with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites О. В. Аверков more than expected).

Fields of papers citing papers by О. В. Аверков

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by О. В. Аверков. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by О. В. Аверков. The network helps show where О. В. Аверков may publish in the future.

Co-authorship network of co-authors of О. В. Аверков

This figure shows the co-authorship network connecting the top 25 collaborators of О. В. Аверков. A scholar is included among the top collaborators of О. В. Аверков based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with О. В. Аверков. О. В. Аверков is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Аверков, О. В., et al.. (2024). Clinical and pharmacogenetic features of patients with upper gastrointestinal lesions at a multidisciplinary hospital: the role of nonsteroidal anti-inflammatory drugs. Drug Metabolism and Personalized Therapy. 39(2). 69–79. 1 indexed citations
2.
Bainey, Kevin R., Robert C. Welsh, Alexandra Arias‐Mendoza, et al.. (2024). Pharmaco-Invasive Strategy With Half-Dose Tenecteplase in Patients With STEMI: Prespecified Pooled Analysis of Patients Aged ≥75 Years in STREAM-1 and 2. Circulation Cardiovascular Interventions. 17(12). e014251–e014251. 1 indexed citations
3.
4.
Werf, Frans Van de, Arsen Ristić, О. В. Аверков, et al.. (2023). STREAM-2: Half-Dose Tenecteplase or Primary Percutaneous Coronary Intervention in Older Patients With ST-Segment–Elevation Myocardial Infarction: A Randomized, Open-Label Trial. Circulation. 148(9). 753–764. 19 indexed citations
5.
Гордеев, И. Г., et al.. (2023). Distant outcomes in patients suffered from COVID-19 with extremely severe lung damage (CT grade 4). Russian Journal of Preventive Medicine. 26(10). 55–55.
6.
Аверков, О. В., et al.. (2022). Safety of Pharmacotherapy in COVID-19 Patients: A Literature Review. SHILAP Revista de lepidopterología. 10(4). 326–344.
7.
Аверков, О. В., et al.. (2022). NEWS2, 4C Mortality Score, COVID-GRAM, Sequential Organ Failure Assessment Quick scales as outcomes assessment tools for severe COVID-19 (pilot retrospective cohort study). CARDIOVASCULAR THERAPY AND PREVENTION. 21(3). 3103–3103. 2 indexed citations
8.
Мирзаев, К. Б., et al.. (2022). The Effect of Carriage of <i>CYP3A5*3</i> and <i>CYP3A4*22</i> Polymorphic Variants on the Safety of Remdesivir Therapy in Patients with COVID-19. SHILAP Revista de lepidopterología. 67(7-8). 45–50.
9.
10.
Аверков, О. В., et al.. (2022). New SARS-CoV-2 Omicron variant — clinical picture, treatment, prevention (literature review). CARDIOVASCULAR THERAPY AND PREVENTION. 21(6). 3228–3228. 6 indexed citations
11.
12.
Аверков, О. В., et al.. (2020). IgM and IgG antibodies against SARS-CoV-2 in neonates born to mothers with COVID-19. Bulletin of Russian State Medical University. 28–30. 2 indexed citations
13.
Гордеев, И. Г., et al.. (2020). COVID-19 infection after recent heart transplantation: a case report. SHILAP Revista de lepidopterología. 25(5). 3904–3904. 2 indexed citations
14.
Аверков, О. В., et al.. (2020). Gastroenterological Manifestations in Patients with COVID-19 Infection. Effective Pharmacotherapy. 16(30). 44–49.
15.
16.
Аверков, О. В., et al.. (2018). Ticagrelor and thrombolysis in myocardial infarction: what does the TREAT study change?. Russian Journal of Cardiology. 65–70. 1 indexed citations
17.
Аверков, О. В., et al.. (2017). MODERN APPROACHES TO ANTICOAGULANT THERAPY OF PULMONARY EMBOLISM: FOCUS ON RIVAROXABAN. Meditsinskiy sovet = Medical Council. 128–133.
18.
19.
Аверков, О. В., et al.. (2015). RANDOMIZED COMPARISON OF TWO APPROACHES TO WARFARIN DOSAGE IN CARDIOVASCULAR HOSPITAL SECTION. SHILAP Revista de lepidopterología. 1 indexed citations
20.
Kobalava, Zhanna, et al.. (2010). Abstract 19378: First Experience with Concomitant AT1 and Neprilysin (NEP 24.11) Inhibition with LCZ696 in Patients with Chronic Heart Failure. Circulation. 122. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hitomi Yuzawa Breakdown of academic impact, for papers by Shunsuke Kiuchi Breakdown of academic impact, for papers by Sergio Agosti Breakdown of academic impact, for papers by Bernard Kadosh Breakdown of academic impact, for papers by Khalid S Ibrahim Breakdown of academic impact, for papers by Michael Ke Wang Breakdown of academic impact, for papers by Harilaos Bogossian Breakdown of academic impact, for papers by V. A. Sulimov Breakdown of academic impact, for papers by Margaret Infeld Breakdown of academic impact, for papers by Andrzej Skrobowski
Rankless by CCL
2026